Deucravacitinib Ritonavir
MinorIn clinical trials, no clinically significant changes in how Deucravacitinib is absorbed, spread through the body and cleared were seen when it was taken together with cyclosporine (a dual Pgp/BCRP inhibitor), fluvoxamine (a CYP1A2 inhibitor), ritonavir (a CYP1A2 inducer), diflunisal (a UGT1A9 inhibitor), pyrimethamine (an OCT1 inhibitor), famotidine (an H2 receptor antagonist), or rabeprazole (a proton pump inhibitor).
Little or no effect is expected. You usually do not need to change anything, but still tell your doctor or pharmacist about every medicine you take.